...and has a discovery pipeline that includes PLD-117, a peptide with TPO-like activity licensed from Receptron Inc....

...hoping to harness the potential of TPO mimetic peptides to treat thrombocytopenia induced by chemotherapy. Receptron Inc....

...activity enhancer Indication: Treat thrombocytopenia due to chemotherapy End point: Safety and platelet count Status: Receptron...

...EPO-R by ERP was unexpected since the receptor is thought to require dimerization for activation. Receptron Inc....